Published June 28, 2019 | Version v1
Presentation Open

HDSA Convention Presentation: From proteins to people: understanding Huntington's disease at the molecular level

  • 1. Structural Genomics Consortium, University of Toronto


Presentation at HDSA Convention 2019 in Boston in "Moving Beyond Mice: Understanding HD in People" session.


Dr. Harding is the recipient of the Huntington's Disease Society of America Berman Topper Career Development Fellowship which funds and supports this research, in addition to generous funding from the CHDI Foundation and the Huntington Society of Canada. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.



Files (29.3 MB)

Name Size Download all
29.3 MB Preview Download